Skip to main content

Jennings Nicole H.'s Form 4 filing

Denbury Inc (DEN) · filed Mar 15, 2023

Accession no.
0000945764-23-000056
Filed
Mar 15, 2023
Trade date
Mar 13, 2023
Filing delay
2 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 1 non-derivative transaction and 1 derivative transaction. Open-market sales total $48.7K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Jennings Nicole H.CIK 0001841028Officer (Vice President and CAO)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Mar 13, 2023Common StockSSaleDisposed−618$78.85F1−$48,729.360,443Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Mar 13, 2023Common StockSSaleDisposed−103$44.93F2−$4,627.790Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.84 to $78.875, inclusive. The reporting person undertakes to provide Denbury Inc., any security holder of Denbury Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

Referenced by the price of 1 transaction in Table I.

F2

Theses Series B Warrants were sold in two lots, each at the price of $44.93. The reporting person undertakes to provide Denbury Inc., any security holder of Denbury Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the sale of the Series B Warrants.

Referenced by the price of 1 transaction in Table II.

Read the full filing on SEC EDGAR (opens in a new tab)